Repurposing existing treatments for new conditions offers a faster, safer, and more cost-effective approach to healthcare.
A panel of 21 experts has identified sildenafil (Viagra), the shingles vaccine Zostavax, and riluzole (used for ALS) as leading candidates for Alzheimer's disease prevention. These selections are based on extensive reviews of clinical evidence and anonymous nominations.
Viagra may be useful for more than just erectile dysfunction. (David Trinks/Unsplash)
Previous studies have linked these treatments to Alzheimer's prevention. Sildenafil, an inhibitor that relaxes blood vessels, has been shown to reduce the accumulation of tau protein, a hallmark of Alzheimer's. The Zostavax vaccine is believed to bolster the immune system against the disease, while riluzole protects neurons from dying. Researchers emphasize that these compounds are suitable for administration to older individuals in well-monitored clinical trials.
While these findings are promising, comprehensive clinical trials are necessary to confirm their efficacy in preventing or reversing Alzheimer's. Drug repurposing remains a vital strategy in the fight against dementia, turning existing medicines into potential treatments for neurodegenerative disorders.